Analysis

The Investment Management Association (IMA) is struggling to find a "perfect" solution to calculating fund performance following the shift to clean pricing, and may have to devise a completely new approach.

The era of 'Big Pharma' is over and companies are transitioning to more complex biological products, explains Tim Crockford from Hermes Sourcecap.

Domestically-focused businesses have been the engine of growth in the UK market. But is this trend over? Revera Asset Management's Glen Nimmo explains.

Skandia has negotiated an average deal of 40bps to 45bps for funds in its WealthSelect panel, Investment Week can reveal

Rathbones' multi-asset head David Coombs explains why he is seeking out property and long/short funds as diversifiers, while making the shift in to large caps.

The absence of any relationship between the monetary base and inflation means no one has any real idea of where the economy is heading. So how can the authorities control inflation and sustain above trend growth? John Clarke, chief investment officer...

Following last year's spectacular market rally, market cap diversity and non-cyclical businesses will be key to achieving growth, explains James Henderson, manager of the Henderson UK Equity Income and Growth fund.

Although inflation has been the dog that has not barked, it would be extraordinary if higher levels did not appear. Protecting against inflation is both cheap and wise, explains Glyn Owen, investment director at Momentum Global Asset Management.

Hugh Cuthbert, manager of SVM's Continental Europe fund, asks whether there will be a level playing field between euro and non-euro currency plays now growth is returning to Europe.

With developed world inflation hovering around the 1%-2% mark, Smith & Williamson's Chris Lynas explores the potential impact on bond markets.